Chemed (CHE) return on equity (ROE)

Return on equity · fiscal 2025
27.1%

Chemed (CHE) earned a return on equity of 27.1% in fiscal 2025 (the year ended December 31, 2025). That is 0.1 percentage points higher than the 27.0% of fiscal 2024. Figures as of 17 Nov 2026, 23:21 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
27.1%
Change on fiscal 2024
+0.1 pts
Highest on record
43.1%fiscal 2021
Lowest on record
15.5%fiscal 2009
Fiscal years on record
182008–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Chemed return on equity (ROE), in more detail

Across the 18 fiscal years on record (2008–2025), the highest was 43.1% in fiscal 2021 and the lowest 15.5% in fiscal 2009. The fiscal 2025 figure is higher than in 71% of the 17 earlier fiscal years on record, whose median is 21.5%.

History · 18 fiscal years

Return on equity by fiscal year

Chemed return on equity (ROE), year by year

Chemed (CHE) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
202527.1% 0.1 pts up
202427.0% 2.4 pts up
202324.6% 6.7 pts down
202231.3% 11.8 pts down
202143.1% 7.6 pts up
202035.4% 5.2 pts up
201930.3% 4.5 pts down
201834.8% 16.6 pts up
201718.2% 2.6 pts down
201620.7% 0.7 pts down
201521.5% 0.5 pts down
201422.0% 4.8 pts up
201317.2% 2.5 pts down
201219.7% 1.1 pts down
201120.8% 3.1 pts up
201017.7% 2.2 pts up
200915.5% 1.5 pts down
200817.0%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

Return on equity at health care companies of similar size

Return on equity of Chemed and comparable companies
CompanyReturn on equityFiscal year
Immunovant IMVT-59.3%2026
Axsome Therapeutics AXSM-207.5%2025
Chemed CHE27.1%2025
Oruka Therapeutics ORKA-22.3%2025
Arrowhead Pharmaceuticals ARWR-1439.4%2026
MSA Safety MSA20.4%2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CHE

Chemed, figure by figure

Chemed (CHE) overview: price, valuation and scorecardAll health care companies by market value

Chemed return on equity (ROE): questions and answers

What is Chemed's return on equity?

Chemed (CHE) earned a return on equity of 27.1% in fiscal 2025 (the year ended December 31, 2025). That is 0.1 percentage points higher than the 27.0% of fiscal 2024.

Is Chemed's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 71% of the 17 earlier fiscal years on record, whose median is 21.5%.

What are the highest and lowest return on equity figures on record for Chemed?

Across the 18 fiscal years on record (2008–2025), the highest was 43.1% in fiscal 2021 and the lowest 15.5% in fiscal 2009.

How is Chemed's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Chemed (CHE) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/CHE/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.